TG Therapeutics Inc. Stock
Price
Target price
€31.65
€31.65
1.490%
0.465
1.490%
€44.83
09:31 / Tradegate
WKN: A1JXW7 / Symbol: TGTX / Name: TG Therapeutics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
TG Therapeutics Inc. Stock
There is an upward development for TG Therapeutics Inc. compared to yesterday, with an increase of €0.47 (1.490%).
Currently there is a rather positive sentiment for TG Therapeutics Inc. with 7 Buy predictions and 3 Sell predictions.
As a result the target price of 44 € shows a positive potential of 39.04% compared to the current price of 31.65 € for TG Therapeutics Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for TG Therapeutics Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of TG Therapeutics Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of TG Therapeutics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
TG Therapeutics Inc. | 1.490% | -11.282% | 3.812% | 99.872% | 1.300% | 743.387% | 94.050% |
Krystal Biotech | -0.760% | -1.083% | 1.757% | -28.507% | -21.978% | 132.843% | - |
Ardelyx Inc. | -0.560% | -0.744% | 5.748% | -46.002% | -35.529% | 521.071% | -45.282% |
Evolus Inc | -1.730% | 3.030% | -3.955% | -19.048% | -19.048% | -23.423% | 95.853% |
Comments
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.
Show more
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for TGTX provided by MarketBeat
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.
Show more
Ratings data for TGTX provided by MarketBeat